Home › Funds › Opaleye Management Inc. › TRAX
Opaleye Management Inc. position in TRAX
FIRST TRACKS BIOTHERAPEUTICS · Health Care
Opaleye Management Inc. reported holding 65,000 shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS) in its Q2 2026 13F filing — a position valued at US$1.3M, representing 0.12% of its reported portfolio and ranking #50 among its reported holdings. Opaleye Management Inc. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Opaleye Management Inc.'s TRAX position evolved
Opaleye Management Inc. first disclosed a stake in TRAX in Q2 2026 at 65,000 shares (US$1.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 65.00K | $1.31M | New |
About TRAX and 13F data
TRAX (FIRST TRACKS BIOTHERAPEUTICS) is a Health Care company. 155 other funds we track also report a position in TRAX — the largest reported positions include EcoR1 Capital, LLC (US$63.9M), TCG Crossover Management, LLC (US$58.3M), Affinity Asset Advisors, LLC (US$40.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TRAX
- EcoR1 Capital, LLC 3.17M sh · $63.87M · Q2 2026
- TCG Crossover Management, LLC 2.90M sh · $58.25M · Q2 2026
- Affinity Asset Advisors, LLC 2.03M sh · $40.88M · Q2 2026
- Trails Edge Capital Partners, LP 1.51M sh · $30.46M · Q2 2026
- Vestal Point Capital, LP 1.01M sh · $20.38M · Q2 2026
- Sanofi 821.92K sh · $16.54M · Q2 2026
- 683 Capital Management, LLC 750.00K sh · $15.09M · Q2 2026
- STEMPOINT CAPITAL LP 622.72K sh · $12.53M · Q2 2026
- Palo Alto Investors LP 603.49K sh · $12.14M · Q2 2026
- Sofinnova Investments, Inc. 565.20K sh · $11.37M · Q2 2026
- Ally Bridge Group (NY) LLC 284.29K sh · $5.72M · Q2 2026
- APIS CAPITAL ADVISORS, LLC 226.00K sh · $4.55M · Q2 2026
More on Opaleye Management Inc.
FAQ
How long has Opaleye Management Inc. held TRAX?
Opaleye Management Inc. has disclosed TRAX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Opaleye Management Inc.'s current position in TRAX?
As of Q2 2026, Opaleye Management Inc. holds 65.00K shares of TRAX (FIRST TRACKS BIOTHERAPEUTICS), valued at $1.31M, representing 0.12% of its reported portfolio and ranking #50.
Has Opaleye Management Inc. been buying or selling TRAX?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. newly opened its position in TRAX.
Which other funds hold TRAX?
Other major institutional holders of TRAX include EcoR1 Capital, LLC, TCG Crossover Management, LLC, Affinity Asset Advisors, LLC, among 155 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.